Cyteir Therapeutics, Inc.
CYT · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4 | -$8 | -$12 | -$9 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | -$2 | -$0 | $0 | $0 |
| Stock-Based Comp. | $1 | $1 | $1 | $1 |
| Change in WC | -$2 | $3 | $0 | $1 |
| Other Non-Cash | $2 | $0 | $1 | $0 |
| Operating Cash Flow | -$5 | -$4 | -$10 | -$7 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | $0 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$4 | -$4 | -$10 | -$7 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $134 | $137 | $147 | $154 |
| End Cash | $130 | $134 | $137 | $147 |
| Free Cash Flow | -$5 | -$4 | -$10 | -$7 |